InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Monahan Joseph, Directeur Scientifique. Insider active across 1 companies, notably Aclaris Therapeutics, Inc.. In total, 11 reports have been logged. Total volume traded: €847k. The latest transaction was filed on 18 April 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations11 total
€452,89230,000 shares@ €15.09640.072% mcap53.5% of flow
Common Stock
SEC:0001209191-22-025032:0·
€385,41627,165 shares@ €14.1880.061% mcap45.5% of flow
Common Stock
SEC:0001209191-22-018501:0·
13,750 shares
Common Stock
SEC:0001209191-22-015829:0·
€4,253383 shares@ €11.10370.0007% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008860·
€4,253383 shares@ €11.10370.0007% mcap0.5% of flow
Common Stock
SEC:0001209191-22-008860:0·
1,050 shares
Common Stock
SEC:0001209191-22-006836·
1,050 shares
Common Stock
SEC:0001209191-22-006836:0·
2,333 shares
Common Stock
SEC:0001209191-21-054530·
2,333 shares
Common Stock
SEC:0001209191-21-054530:0·
50,000 shares
Common Stock
SEC:0001209191-21-037478·
50,000 shares
Common Stock
SEC:0001209191-21-037478:0·
11 of 11 declarations
About Monahan Joseph
Joseph Monahan is Chief Scientific Officer at Aclaris Therapeutics, Inc. He is responsible for leading the company's research and development initiatives, contributing to innovation and product advancement. His scientific expertise is essential for guiding research projects and ensuring compliance with industry regulations. Through his leadership, he plays a key role in the development of therapeutic solutions.
